Compare Novartis AG (NVS) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs United Microelectronics Corp — how do they compare? Novartis AG trades at $142.04 (market cap $274.00B), while United Microelectronics Corp trades at $23.13 (market cap $58.54B). The key difference: Novartis AG is far larger — about 4.7× United Microelectronics Corp's market cap, and Novartis AG pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and United Microelectronics Corp for 42 Days on average.
| NVS | UMC | |
|---|---|---|
Market Cap | $274.00B | $58.54B |
Volume | 1,852,137 | 8,050,715 |
Sector | Health | Technology |
52-Week High | $168.62 | $28.02 |
52-Week Low | $121.80 | $7.02 |
Typical Hold Time | 82 Days | 42 Days |
Enterprise Value | $315.32B | $55.62B |
Dividend Yield | 3.31% | 1.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.11, up 1.65% with mixed technical signals showing neutral momentum. The company maintains strong profitability with 22.5% net margins and recently announced a $7.8B licensing deal with China's Abogen. Recent earnings show two beats and one miss in the last three quarters, with Q3 2026 results pending. The stock trades below the consensus price target of $146, suggesting modest upside potential from current levels.
Novartis presents a balanced investment case with strong cash flow generation and profitability offset by recent clinical setbacks and M&A scrutiny. The $7.8B Abogen partnership expands the autoimmune pipeline, but investors face risks from patent cliffs and drug development failures. Analyst consensus leans cautious with 68% hold ratings, reflecting uncertainty around pipeline execution amid ongoing strategic repositioning.
UMC trades at $22.82, down 1.6% on the day, with a bullish technical signal despite mixed moving average indicators. The company has delivered three consecutive earnings beats, with Q2 2026 EPS of $0.54 significantly exceeding the $0.16 estimate. Revenue growth remains steady, projected to reach $250.7B in 2026, while net income margin is expected to rebound to 32.75%. Recent news highlights strong AI-driven demand and specialty chip expansion.
UMC presents a mixed investment case with strong earnings momentum and AI growth potential offset by declining profit margins and competitive pressures. The stock appears moderately valued with a P/E of 22.48, while analyst consensus leans Hold (53.33%) with some institutional selling activity. Key risks include semiconductor cycle volatility and AI spending concerns impacting foundry stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
